
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, discusses some of the ways in which e-prescribing trumps traditional prescriptions.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, discusses some of the ways in which e-prescribing trumps traditional prescriptions.
This video was recorded at the 2015 NCPA Annual Convention.






